GLP-1RAs in the cardiovascular system In the cardiovascular system, GLP-1 can reduce cardiac ischemia-reperfusion injury through the activation of specific signaling pathways, such as the PI3K/Akt pathway
, Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial, Nat
Many GLP-1 weight loss medications are considered for adults with obesity or adults with overweight and at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes risk, or similar metabolic concerns
Because swallowing food triggers GLP-1 release from the gut, which dramatically amplifies the insulin response
It combines the convenience of telehealth with clinically guided treatment, making it appealing to those who want a structured approach without in-person visits
For the best outcomes, its important to follow your healthcare providers guidance and maintain a healthy lifestyle, including regular exercise and a balanced diet